Ignite Creation Date:
2024-05-06 @ 6:09 PM
Last Modification Date:
2024-10-26 @ 2:43 PM
Study NCT ID:
NCT05568680
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2022-09-28
Brief Title:
SynKIR-110 for Mesothelin Expressing Ovarian Cancer Cholangiocarcinoma or Mesothelioma
Sponsor:
Verismo Therapeutics
Organization:
Verismo Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-30
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-28
First Submit QC Date:
October 5 2022
Study First Post Date:
2022-10-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-20
Last Update Post Date:
2024-07-10
Last Update Post Date Type:
ACTUAL